CIPROFLOXACIN, 250mg/5ml, gran.+ solvent oral susp

STD DORACIPR1S-

Valid Article

Former Code(s): -X DORAZNL0324
Article is intended to be used with children (<12 years) ONLY.
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J01MA02
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

CIPROFLOXACIN

Therapeutic Action

Fluoroquinolone antibacterial

Indications

Shigellosis, uncomplicated cutaneous anthrax

Uncomplicated acute pyelonephritis, acute prostatitis, acute cystitis in non-pregnant women in the event of previous treatment failure

Plague

Completion treatment following therapy with parenteral ciprofloxacin

Some restricted information has been hidden. Sign in to see this information

Instructions for use

The oral suspension is intended for paediatric use.

Drink a lot of liquid during treatment (risk of crystalluria).

Storage

  • Below 25ºC
  • Solvent for oral suspension: do not freeze.